Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CeriBell, Inc. - Common Stock (NQ:CBLL)

12.89 +0.31 (+2.46%)
Streaming Delayed Price Updated: 10:51 AM EDT, Aug 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CeriBell, Inc. - Common Stock

< Previous 1 2 Next >
CeriBell (CBLL) Q2 Revenue Jumps 38%
Via The Motley Fool
Topics Artificial Intelligence
Ceribell Reports Second Quarter 2025 Financial Results
From Ceribell
Via GlobeNewswire
Earnings Scheduled For August 5, 2025
 
Via Benzinga
Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference
From Ceribell
Via GlobeNewswire
Earnings Scheduled For May 8, 2025
 
Via Benzinga
Earnings Scheduled For February 25, 2025
 
Via Benzinga
Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025
From Ceribell
Via GlobeNewswire
Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
Complaints Assert Infringement of Patents Related to Point-of-Care Electroencephalography (EEG) Technology 
From Ceribell
Via GlobeNewswire
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference
From Ceribell
Via GlobeNewswire
Ceribell Reports First Quarter 2025 Financial Results
From Ceribell
Via GlobeNewswire
Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference
From Ceribell
Via GlobeNewswire
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems
From Ceribell
Via GlobeNewswire
Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025
From Ceribell
Via GlobeNewswire
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older
Powered by Clarity, the Ceribell System will enable rapid, bedside detection, diagnosis and treatment of non-convulsive seizures in children experiencing neurological emergencies 
From Ceribell
Via GlobeNewswire
Ceribell's Retail Popularity Surges After Small-Cap Medtech Firm Assures No Tariff Impact Until Q4
According to the company, its current U.S. inventory is expected to cover demand through the third quarter of 2025. 
Via Stocktwits
Topics Government World Trade
Top stock movements in today's session.
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday
 
Via Benzinga
Top stock movements in today's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
CeriBell's IPO Lockup Ends April 9 - Here's Why We're Shorting It
The stock has shown solid performance despite market volatility, making it likely that insiders will sell to cash in on gains. 
Via Talk Markets
Topics Initial Public Offering
Discover the top movers in Monday's pre-market session.
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
This Lattice Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
 
Via Benzinga
Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results
From Ceribell
Via GlobeNewswire
Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference
From Ceribell
Via GlobeNewswire
Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
From Ceribell
Via GlobeNewswire
Why MicroStrategy Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
Shares of MicroStrategy Incorporated (NASDAQ:MSTR) rose sharply in today's pre-market trading. 
Via Benzinga
Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From Ceribell
Via GlobeNewswire
Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing
From Ceribell
Via GlobeNewswire
Ceribell Reports Third Quarter 2024 Financial Results
From Ceribell
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.